Drug details
Tecentriq (atezolizumab injection)
type of PD-1PD-L1 Inhibitors
Tecentriq (atezolizumab) Injection for intravenous infusion is a monoclonal antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (cancer) who have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- loss of appetite,
- itching,
- dark urine,
- rash,
- vomiting,
- diarrhea,
- fever,
- pale skin,
- lightheadedness,
- confusion,
- chills,
- tiredness,
- clay-colored stools,
- chest pain,
- dizziness,
- blurred vision,
- sudden numbness,
- constipation,
- muscle aches,
- headache,
- fainting,
- nervousness,
- pounding in the ears,
- weakness,
- cough,
- tightness in the chest,
- darkening of the skin,
- sore throat,
- nosebleed,
- hoarseness,
- lower back or side pain,
- body aches or pain,
- sweating
- drowsiness,
- flushed or dry skin,
- fruit-like breath odor,
- seizures,
- rapid weight gain,
- anxiety,
- trouble sleeping,
- depression,
- irritability,
- pain,
- indigestion,
- sneezing,
- double vision,
- tenderness,
- bloating,
- yellowing of eyes and skin (jaundice),
- little or no urine,
- cold feeling,
- joint or muscle pain,
- stomach cramps,
- bladder pain,
- frequent urge to urinate,
- increased urination, and
- black or tarry stools,
- increased hunger,
- slow or fast heartbeat,
- upper right abdominal pain,
- rapid or shallow breathing,
- redness of the skin,
- sores or white spots in the mouth,
- loss of voice,
- unusual bleeding or bruising,
- stuffy or runny nose,
- earache,
- burning or painful urination,
- blood or cloudy urine,
- tingling of the hands, arms, legs or feet,
- tingling in the hands and feet,
- watery or bloody diarrhea,
- difficulty chewing, swallowing, or talking,
- drooping eye lids,
- dry skin and hair,
- general feeling of discomfort or illness,
- inability to move the arms and legs,
- muscle cramp and stiffness,
- numbness in the hands, feet, or lips,
- pins and needles,
- sensitivity to heat,
- stabbing pain,
- stiffness in the neck or back,
- blistering, peeling, or loosening of the skin,
- joint stiffness or swelling,
- stomach pain that radiates to the back,
- red skin lesions with a purple center,
- red, irritated eyes,
The following drugs are related to Tecentriq, either as a replacement or used together:
- Rybrevant (amivantamab-vmjw for injection)
- Balversa (erdafitinib tablets)
- Theracys (bcg live (intravesical))
- Tabrecta (capmatinib tablets)
- Platinol (cisplatin for injection)
- Platinol-AQ (cisplatin injection)
- Cysview (hexaminolevulinate hydrochloride intravesical solution)
- Orserdu (elacestrant tablets)
- Padcev (enfortumab vedotin-ejfv for injection)
- Exkivity (mobocertinib capsules)
- Lytgobi (futibatinib tablets)
- Gemzar (gemcitabine hcl)
- Sancuso (granisetron transdermal system)
- Hepzato (melphalan for injection)
- Mutamycin (mitomycin)
- Pemfexy (pemetrexed injection for intravenous use)
- Retevmo (selpercatinib capsules)
- Tepmetko (tepotinib tablets)
- Valstar (valrubicin)